IRIS UniCatt

Galli, Eugenio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.528
EU - Europa 1.390
NA - Nord America 1.284
SA - Sud America 356
AF - Africa 38
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.597
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.228
SG - Singapore 742
CN - Cina 402
IT - Italia 312
BR - Brasile 299
DE - Germania 254
SE - Svezia 177
FI - Finlandia 147
PL - Polonia 147
FR - Francia 103
IN - India 88
VN - Vietnam 60
GB - Regno Unito 57
ID - Indonesia 43
IE - Irlanda 43
KR - Corea 38
CA - Canada 30
RU - Federazione Russa 29
HK - Hong Kong 25
AT - Austria 24
CZ - Repubblica Ceca 22
BD - Bangladesh 19
MX - Messico 18
AR - Argentina 16
ES - Italia 14
TR - Turchia 14
BE - Belgio 13
IQ - Iraq 12
JP - Giappone 12
NL - Olanda 12
CO - Colombia 11
SA - Arabia Saudita 11
UZ - Uzbekistan 10
VE - Venezuela 10
ZA - Sudafrica 10
CI - Costa d'Avorio 9
EC - Ecuador 9
UA - Ucraina 8
IL - Israele 7
LT - Lituania 7
KE - Kenya 6
MA - Marocco 6
IR - Iran 5
UY - Uruguay 5
AZ - Azerbaigian 4
JO - Giordania 4
KZ - Kazakistan 4
PK - Pakistan 4
BO - Bolivia 3
BY - Bielorussia 3
KG - Kirghizistan 3
KW - Kuwait 3
NP - Nepal 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
HU - Ungheria 2
LB - Libano 2
LU - Lussemburgo 2
LV - Lettonia 2
OM - Oman 2
PY - Paraguay 2
QA - Qatar 2
TN - Tunisia 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CH - Svizzera 1
CR - Costa Rica 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.597
Salva come PNG Salva come JPEG
Città #
Singapore 373
Munich 155
Warsaw 140
Ashburn 138
Chandler 129
Hefei 105
Rome 104
Helsinki 87
Beijing 78
Los Angeles 62
Hyderabad 57
Milan 56
Chicago 52
New York 50
The Dalles 47
Dublin 39
Seoul 38
Jakarta 36
Florence 35
Frankfurt am Main 34
Dallas 33
Kent 32
Fairfield 31
Turku 27
Lappeenranta 25
Santa Clara 25
Hong Kong 24
Seattle 20
Brooklyn 18
Nuremberg 18
London 17
Brno 15
Moscow 15
Bremen 14
Ho Chi Minh City 14
São Paulo 14
Wilmington 14
Boston 13
Brussels 13
Düsseldorf 13
Hanoi 13
Marseille 13
Paris 13
Woodbridge 13
Belo Horizonte 12
Buffalo 12
Houston 12
Montreal 12
Princeton 12
Tokyo 12
Lauterbourg 11
Toronto 11
Vienna 11
San Mateo 10
Tashkent 10
Abidjan 9
Campinas 9
Chennai 9
Redmond 9
Rio de Janeiro 9
Stockholm 9
Charlotte 8
Falls Church 8
Poplar 8
Atlanta 7
Johannesburg 7
Manchester 7
Phoenix 7
Tampa 7
Bogotá 6
Cambridge 6
Caracas 6
Cattolica 6
Curitiba 6
Baghdad 5
Brasília 5
Columbus 5
Da Nang 5
Dhaka 5
Falkenstein 5
Governador Valadares 5
Mexico City 5
Nairobi 5
Orem 5
Portsmouth 5
Pune 5
Riyadh 5
Salt Lake City 5
Washington 5
Amsterdam 4
Bexley 4
Biên Hòa 4
Brdo 4
Casablanca 4
Catania 4
Dong Ket 4
Gioia Tauro 4
Guangzhou 4
Guarulhos 4
Hortolândia 4
Totale 2.649
Salva come PNG Salva come JPEG
Nome #
Interleukin-31 and thymic stromal lymphopoietin expression in plasma and lymph node from Hodgkin lymphoma patients 270
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 261
CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma 197
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 121
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 119
Comorbidity assessment to determine prognosis in older adult patients with classical Hodgkin lymphoma 115
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 111
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 107
Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study 100
Subcutaneous immunoglobulins in chronic lymphocytic leukemia with secondary antibody deficiency. A monocentric experience during Covid-19 pandemics 100
Unselected donor-derived hematopoietic stem cells boost for Chimeric Antigen Receptor T-cell associated hematotoxicity 99
Burkitt lymphoma as fourth neoplasia in a patient affected by cowden syndrome with a novel PTEN germline pathogenic variant 98
Nutritional status and quality of life in adults undergoing allogeneic hematopoietic stem cell transplantation 96
Inflammation and acute cardiotoxicity in adult hematological patients treated with CAR-T cells: results from a pilot proof-of-concept study 94
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T cells 94
Triple post transplant cyclophosphamide (PTCY) based GVHD prophylaxis: HLA matched versus HLA haploidentical transplants. 87
Acute erythroid leukemia with TP53 mutation and BCR/ABL1: challenges in classification and management 86
Aggressive Light Chain Myeloma Originating a Double Peak on Serum Electrophoresis: What's Underneath? 84
Unlocking Predictive Power: Quantitative Assessment of CAR-T Expansion with Digital Droplet Polymerase Chain Reaction (ddPCR) 83
Haploidentical bone marrow transplantation for AML in remission following TBF conditioning: a long-term follow up 83
Impact of SARS-CoV-2 vaccination and passive prophylaxis with tixagevimab/cilgavimab on CAR-T patients: a three-year regional experience from the Italian covid pandemic 81
Treatment options for elderly/unfit patients with chronic lymphocytic leukemia in the era of targeted drugs: A comprehensive review 81
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 80
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-t Cells 79
CAR-T treatment is safe and effective in adult patients with Down syndrome and B-cell acute lymphoblastic leukemia (B-ALL) 79
Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study 78
COVID-19 in patients with Chronic Lymphocytic Leukemia treated with venetoclax: what is the role of anti-CD20 antibody? 78
Effect of HLA mismatch on post-transplant infections in allogeneic hematopoietic stem cell transplantation with PTCy-based GvHD prophylaxis 77
The CD4/CD8 ratio of infused CD19-CAR-T is a prognostic factor for efficacy and toxicity 75
Risk factors for hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation in a letermovir-exposed CMV-free population receiving PTCy 74
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 73
What is the best treatment strategy before autologous peripheral blood stem cell transplantation in POEMS syndrome? 73
CAR-T from cord blood in a patient with Ph+ acute lymphoblastic leukemia relapsing after hematopoietic stem cell transplantation 72
Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b-precursor acute lymphoblastic leukaemia: Case reports and literature review 71
G-CSF does not worsen toxicities and efficacy of CAR-T cells in refractory/relapsed B-cell lymphoma 66
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 63
Impact of Pretransplant Salvage Therapies on Outcome of Hodgkin Lymphoma Patients Performing Allogeneic Transplant 63
Prognostic factors in hodgkin lymphoma 60
Treatment Sequencing and Outcome of Chronic Lymphocytic Leukemia Patients Treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Thirty-Year Single-Center Experience 59
Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study 59
The impact of donor-specific antibodies’ presence on the outcome post-allogeneic hematopoietic stem cell transplantation: a survey from a single center 58
First-line treatment of Waldenström's macroglobulinemia in Italy: A multicenter real-life study on 547 patients to evaluate the long-term efficacy and tolerability of different chemoimmunotherapy strategies 58
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T) 57
Effect of early granulocyte-colony-stimulating factor administration in the prevention of febrile neutropenia and impact on toxicity and efficacy of anti-CD19 CAR-T in patients with relapsed/refractory B-cell lymphoma 57
Coagulopathy in CAR-T: Critical concern or mere blip? 57
Kinetics of lymphocytosis in naïve chronic lymphocytic leukemia patients treated with covalent Bruton's tyrosine kinase inhibitors: An Italian multicenter real-life experience 54
Choice of commercially available CAR-T cell products for r/r DLBCL & PMBCL in Europe: a survey on behalf of the cellular therapy & immunobiology working party (CTIWP) of the EBMT 54
Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b-precursor acute lymphoblastic leukaemia: Case reports and literature review 53
Hemorrhagic cystitis in allogeneic stem cell transplantation: a role for age and prostatic hyperplasia 52
Spontaneous resolution of “therapy-related myelodysplasia” occurred after treatment with CAR-T cells: All that glitters is not gold 52
Predicting the outcome for patients with myelofibrosis undergoing an allogeneic hemopoietic stem cell transplant 51
Vascular inflammation in patients undergoing anti-CD19 chimeric antigen receptor-T cells for haematologic malignancies: a call for cardiovascular surveillance 48
Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma 44
VEGF as a Relapse Marker and an Intensity of Disease Marker in Patients Affected by POEMS Syndrome Treated With Autologous Peripheral Blood Stem Cell Transplantation 43
Is Allogeneic Transplantation an Option in Patients Affected by Concurrent Myelofibrosis and Chronic Myeloid Leukemia (CML)? 31
Frail is not fail: Limited impact of comorbidities on non‐relapse mortality and safety in patients with LBCL treated with CAR‐T 19
Frail is not fail: Limited impact of comorbidities on non-relapse mortality and safety in patients with LBCL treated with CAR-T 12
Predicting therapy-related myeloid neoplasms after CAR-T with the Clonal Haematopoiesis Risk Score (CHRS) 11
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 10
Inflammation and acute cardiotoxicity in adult hematological patients treated with CAR-T cells: results from a pilot proof-of-concept study 10
Routine prophylaxis with levetiracetam offers no benefit in CD19 CAR-T for LBCL: a multicenter propensity-matched study 10
Predictors of Neurotoxicity in a Large Cohort of Italian Patients Undergoing Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy 5
Totale 4.692
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.795
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.795
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202149 0 0 0 0 0 6 9 2 7 7 12 6
2021/2022135 9 5 5 5 14 8 3 14 6 6 27 33
2022/2023450 74 51 17 68 30 54 35 27 48 21 23 2
2023/2024412 10 72 28 42 6 52 30 38 7 34 34 59
2024/20251.795 40 30 79 172 119 96 124 79 190 172 418 276
2025/20261.596 421 139 219 327 466 24 0 0 0 0 0 0
Totale 4.692